Psychosocial and Pharmacological Management of Pain in Pediatric Sickle Cell Disease

References

• . Hassell KL. Population estimates of sickle cell disease in the US. Am J Prev Med. 2010;38(4):S512–S521
   PubMed Web of Science ®Google Scholar
• . National Heart Lung and Blood Institute. Sickle Cell Anemia: Who Is at Risk? Bethesda, MD: US Department of Health and Human Services; 2009
   Google Scholar
• . Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP. Sickle cell disease: a general overview. Neth J Med. 2004;62(10):364–374
   PubMed Web of Science ®Google Scholar
• . Jerrell JM, Tripathi A, Stallworth JR. Pain management in children and adolescents with sickle cell disease. Am J Hematol. 2011;86(1):82–84
   PubMed Web of Science ®Google Scholar
• . Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340(13):1021–1030
   PubMed Web of Science ®Google Scholar
• . National Heart Lung and Blood Institute. The Management of Sickle Cell Disease. Bethesda, MD: National Institutes of Health; 2002
   Google Scholar
• . Whalen D, Houchens R, Elixhauser A. 2003 HCUP KIDS' Inpatient Database (KID) Comparison Report. Rockville, MD: Agency for Healthcare Research and Quality, US Department of Health and Human Services; 2006
   Google Scholar
• . Smith WR, Scherer M. Sickle-cell pain: advances in epidemiology and etiology. Hematology Am Soc Hematol Educ ProgrAm. 2010;2010:409–415
   PubMedGoogle Scholar
• . Platt OS, Brambilla DJ, Rosse WF, . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644
   PubMed Web of Science ®Google Scholar
• . Yaster M, Kost-Byerly S, Maxwell LG. The management of pain in sickle cell disease. Pediatr Clin N Am. 2000;47(3):699
   PubMed Web of Science ®Google Scholar
• . Jacox A. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. Glenview, IL: American Pain Society; 1999
   Google Scholar
• . Ballas SK. Pain management of sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):785–802
   PubMed Web of Science ®Google Scholar
• . Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442):1343–1360
   PubMed Web of Science ®Google Scholar
• . Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA. Vasoocclusive painful events in sickle cell disease: impact on child well-being. Pediatr Blood Cancer. 2010;54(1):92–97
   PubMed Web of Science ®Google Scholar
• . Platt OS, Thorington BD, Brambilla DJ, . Pain in sickle-cell disease—rates and risk-factors. N Engl J Med. 1991;325(1):11–16
   PubMed Web of Science ®Google Scholar
• . Barbarin OA, Whitten CF, Bonds SM. Estimating rates of psychosocial problems in urban and poor children with sickle cell anemia. Health Social Work. 1994;19(2):112–119
   PubMed Web of Science ®Google Scholar
• . Shapiro BS, Dinges DF, Orne EC, . Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain. 1995;61(1):139–144
   PubMed Web of Science ®Google Scholar
• . Lemanek KL, Horwitz W, Ohene-Frempong K. A multiperspective investigation of social competence in children with sickle cell disease. J Pediatr Psychol. 1994;19(4):443–456
   PubMed Web of Science ®Google Scholar
• . Fuggle P, Shand PA, Gill LJ, Davies SC. Pain, quality of life, and coping in sickle cell disease. Arch Dis Child. 1996;75(3):199–203
   PubMed Web of Science ®Google Scholar
• . Mitchell MJ, Lemanek K, Palermo TM, Crosby LE, Nichols A, Powers SW. Parent perspectives on pain management, coping, and family functioning in pediatric sickle cell disease. Clin Pediatr. 2007;46(4):311–319
   PubMed Web of Science ®Google Scholar
• . Palermo TM. Impact of recurrent and chronic pain on child and family daily functioning: a critical review of the literature. J Dev Behav Pediatr. 2000;21(1):58–69
   PubMed Web of Science ®Google Scholar
• . Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323–327
   PubMed Web of Science ®Google Scholar
• . Field JJ, Knight-Perry JE, Debaun MR. Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines. Curr Opin Hematol. 2009;16(3):173–178
   PubMed Web of Science ®Google Scholar
• . Thomas VN, Wilson-Barnett J, Goodhart F. The role of cognitive-behavioural therapy in the management of pain in patients with sickle cell disease. J Adv Nurs. 1998;27(5):1002–1009
   PubMed Web of Science ®Google Scholar
• . Kazak AE, Simms S, Rourke MT. Family systems practice in pediatric psychology. J Pediatr Psychol. 2002;27(2):133–143
   PubMed Web of Science ®Google Scholar
• . Gil KM, Wilson JJ, Edens JL, . Cognitive coping skills training in children with sickle cell disease pain. Int J Behav Med. 1997;4(4):364–377
   PubMed Web of Science ®Google Scholar
• . Gil KM, Anthony KK, Carson JW, Redding-Lallinger R, Daeschner CW, Ware RE. Daily coping practice predicts treatment effects in children with sickle cell disease. J Pediatr Psychol. 2001;26(3):163–173
   PubMed Web of Science ®Google Scholar
• . Broome ME, Maikler V, Kelber S, Bailey P, Lea G. An intervention to increase coping and reduce health care utilization for school-age children and adolescents with sickle cell disease. J Natl Black Nurses AsSoc. 2001;12(2):6–14
   PubMedGoogle Scholar
• . Thomas VJ, Dixon AL, Milligan P. Cognitive-behaviour therapy for the management of sickle cell disease pain: an evaluation of a community-based intervention. Br J Health Psychol. 1999;4:209–229
   Web of Science ®Google Scholar
• . Barakat LP, Schwartz LA, Salamon KS, Radcliffe J. A family-based randomized controlled trial of pain intervention for adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2010;32(7):540–547
   PubMed Web of Science ®Google Scholar
• . Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol. 2003;120(5):744–752
   PubMed Web of Science ®Google Scholar
• . Kraemer FW, Rose JB. Pharmacologic management of acute pediatric pain. Anesthesiol Clin. 2009;27(2):241–268
   PubMedGoogle Scholar
• . Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol. 1996;102:9–21
   Google Scholar
• . Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. Pediatr Clin North Am. 2000;47(3):487–512
   PubMed Web of Science ®Google Scholar
• . Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative pain management in children. Drug Saf. 1997;16(5):309–329
   PubMed Web of Science ®Google Scholar
• . Dix P, Prosser DP, Streete P. A pharmacokinetic study of piroxicam in children. Anaesthesia. 2004;59(10):984–987
   PubMed Web of Science ®Google Scholar
• . Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 2006;148(3):245–254
   PubMed Web of Science ®Google Scholar
• . Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol. 2010;85(1):24–28
   PubMed Web of Science ®Google Scholar
• . Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med. 1994;330(11):733–737
   PubMed Web of Science ®Google Scholar
• . Vandy Black L, Smith WR. Evidence-based mini-review: Are systemic corticosteroids an effective treatment for acute pain in sickle cell disease? Hematology Am Soc Hematol Educ ProgrAm. 2010;2010:416–417
   PubMedGoogle Scholar
• . Grisham JE, Vichinsky EP. Ketorolac versus meperidine in vaso-occlusive crisis: a study of safety and efficacy. Int J Pediatr Hematol/Oncol. 1996;3:239–247
   Web of Science ®Google Scholar
• . Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9(1):53–68
   PubMedGoogle Scholar
• . Hardwick WE Jr, Givens TG, Monroe KW, King WD, Lawley D. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Pediatr Emerg Care. 1999;15(3):179–182
   PubMed Web of Science ®Google Scholar
• . Eke FU, Obamyonyi A, Eke NN, Oyewo EA. An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis. Trop Med Int Health. 2000;5(2):81–84
   PubMed Web of Science ®Google Scholar
• . Rogers ZR, Dale JC, Bernini JC, Reisch JS, Primm PA. Dexamethasone shortens the duration of painful events requiring hospitalisation in children with sickle cell disease: results of a randomized double-blind placebo-controlled trial. Blood. 1995;88:250a
   Google Scholar
• . Miller ST, Kim HY, Weiner D, . Inpatient management of sickle cell pain: A “snapshot” of current practice. Am J Hematol. 2012;87(3):333–336
   PubMed Web of Science ®Google Scholar
• . Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs. 2003;5(4):229–241
   PubMedGoogle Scholar
• . Pert CB, Pasternak G, Snyder SH. Opiate receptor: Demonstration in nervous tissue. In: Snyder SH, ed. Science and Psychiatry: Ground-breaking Discoveries in Molecular Neuroscience. Arlington, VA: American Psychiatric Publishing; 2008:19–26
   Google Scholar
• . van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007;82(11):955–960
   PubMed Web of Science ®Google Scholar
• . Dampier CD, Smith WR, Wager CG, . IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials. 2013;10(2):319–331
   PubMed Web of Science ®Google Scholar
• . Jacobson SJ, Kopecky EA, Joshi P, Babul N. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet. 1997;350(9088):1358–1361
   PubMed Web of Science ®Google Scholar
• . Kaslow NJ, Collins MH, Loundy MR, Brown F, Hollins LD, Eckman J. Empirically validated family intervetions for pediatric psychology: sickle cell disease as an exemplar. J Pediatr Psychol. 1997;22(2):213–227
   PubMed Web of Science ®Google Scholar
• . Cozzi L, Tryon WW, Sedlacek K. The effectiveness of biofeedback-assisted relaxation in modifying sickle cell crises. Biofeedback Self-Regul. 1987;12(1):51–61
   PubMedGoogle Scholar
• . Dinges DF, Whitehouse WG, Orne EC, . Self-hypnosis training as an adjunctive treatment in the management of pain associated with sickle cell disease. Int J Clin Exp Hypnosis. 1997;45(4):417–432
   PubMed Web of Science ®Google Scholar
• . Ballas SK. Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ ProgrAm. 2007;2007:97–105
   Google Scholar
• . Yaster M, Kost-Byerly S, Maxwell LG. The management of pain in sickle cell disease: acute pain in children. Pediatr Clin N Am. 2000;47:699–710
   PubMed Web of Science ®Google Scholar
• . Levenson JL, McClish DK, Dahman BA, . Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med. 2008;70(2):192–196
   PubMed Web of Science ®Google Scholar
• . Laurence B, George D, Woods D. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. J Natl Med AsSoc. 2006;98:365–369
   PubMed Web of Science ®Google Scholar
• . Ferster A, Tahriri P, Vermylen C, . Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;97(11):3628–3632
   PubMed Web of Science ®Google Scholar
• . Strouse JJ, Lanzkron S, Beach MC, . Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122(6):1332–1342
   PubMed Web of Science ®Google Scholar
• . Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003;289(9):1136–1142
   PubMed Web of Science ®Google Scholar
• . Orringer EP, Casella JF, Ataga KI, . Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial. JAMA. 2001;286(17):2099–2106
   PubMed Web of Science ®Google Scholar
• . Gibbs WJ, Hagemann TM. Purified poloxamer 188 for sickle cell vaso-occlusive crisis. Ann Pharmacother. 2004;38(2):320–324
   PubMed Web of Science ®Google Scholar
• . Chen E, Cole SW, Kato PM. A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol. 2004;29(3):197–209
   PubMed Web of Science ®Google Scholar
• . Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood. 2000;95:1130–1137
   PubMed Web of Science ®Google Scholar